Aureus Asset Management Decreased Boston Scientific Com (BSX) Position By $3.66 Million; Gridsum Holding Ads (GSUM) Shorts Lowered By 5.72%

November 14, 2017 - By olga

Gridsum Holding Ads (NASDAQ:GSUM) had a decrease of 5.72% in short interest. GSUM’s SI was 634,600 shares in November as released by FINRA. Its down 5.72% from 673,100 shares previously. With 191,000 avg volume, 3 days are for Gridsum Holding Ads (NASDAQ:GSUM)’s short sellers to cover GSUM’s short positions. The SI to Gridsum Holding Ads’s float is 4.02%. About 22,811 shares traded. Gridsum Holding Inc – ADR (NASDAQ:GSUM) has 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Aureus Asset Management Llc decreased Boston Scientific Corp Com (BSX) stake by 18.96% reported in 2017Q2 SEC filing. Aureus Asset Management Llc sold 135,640 shares as Boston Scientific Corp Com (BSX)’s stock rose 4.02%. The Aureus Asset Management Llc holds 579,918 shares with $16.08 million value, down from 715,558 last quarter. Boston Scientific Corp Com now has $38.90 billion valuation. The stock declined 0.42% or $0.12 reaching $28.33 per share. About 2.61M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since November 14, 2016 and is uptrending. It has outperformed by 2.42% the S&P500.

Among 28 analysts covering Boston Scientific Corporation (NYSE:BSX), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 70 analyst reports since July 27, 2015 according to SRatingsIntel. Needham maintained the stock with “Buy” rating in Friday, February 3 report. The firm has “Buy” rating by Needham given on Friday, November 3. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Needham on Friday, April 28. The firm has “Strong Buy” rating given on Monday, October 5 by Raymond James. The rating was upgraded by Argus Research to “Buy” on Thursday, September 1. The stock has “Hold” rating by Jefferies on Tuesday, June 27. The company was initiated on Thursday, June 9 by Guggenheim. As per Wednesday, June 28, the company rating was maintained by Needham. BTIG Research downgraded the shares of BSX in report on Monday, May 23 to “Neutral” rating. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Hold” rating by Jefferies on Tuesday, September 5.

Aureus Asset Management Llc increased American Wtr Wks Co Inc New Com (NYSE:AWK) stake by 9,751 shares to 177,642 valued at $13.85M in 2017Q2. It also upped Sherwin Williams Co Com (NYSE:SHW) stake by 10,550 shares and now owns 45,240 shares. Charter Communications Inc New Cl A was raised too.

Investors sentiment increased to 1.03 in 2017 Q2. Its up 0.14, from 0.89 in 2017Q1. It improved, as 41 investors sold BSX shares while 173 reduced holdings. 56 funds opened positions while 165 raised stakes. 1.22 billion shares or 0.64% less from 1.23 billion shares in 2017Q1 were reported. Deroy And Devereaux Private Counsel reported 636,377 shares stake. Los Angeles Capital And Equity Research invested in 3.04 million shares. Commonwealth Equity Svcs Inc, a Massachusetts-based fund reported 59,412 shares. Wade G W And holds 0.1% or 28,898 shares. Redwood Lc reported 444,394 shares. 156,164 were reported by Columbia Prtn L L C Inv. Tci Wealth invested 0.04% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Fincl Services Corp has invested 0.19% in Boston Scientific Corporation (NYSE:BSX). Winslow Mngmt holds 1.66% or 11.21M shares in its portfolio. Bluestein R H And accumulated 55,000 shares. Amica Pension Fund Board Of Trustees has 69,007 shares for 0.24% of their portfolio. Millennium Management Lc owns 1.11 million shares. Ls Invest Advisors Ltd Limited Liability Company reported 0.07% of its portfolio in Boston Scientific Corporation (NYSE:BSX). First Financial Bank Of Omaha holds 0.37% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 212,515 shares. 309,513 are owned by Cibc Mkts.

Since May 17, 2017, it had 0 insider buys, and 4 insider sales for $1.16 million activity. Pierce David A had sold 2,972 shares worth $82,313 on Thursday, June 1. $271,261 worth of stock was sold by Pratt Timothy A. on Thursday, June 1. Another trade for 15,500 shares valued at $422,369 was made by Phalen Michael P. on Tuesday, May 30. Ballinger Kevin J. had sold 28,864 shares worth $754,454.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 1. They expect $0.34 earnings per share, up 13.33% or $0.04 from last year’s $0.3 per share. BSX’s profit will be $466.85 million for 20.83 P/E if the $0.34 EPS becomes a reality. After $0.31 actual earnings per share reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 9.68% EPS growth.

Gridsum Holding Inc. is a holding company. The company has market cap of $258.89 million. The Firm provides data analysis software for multinational and domestic enterprises, and government agencies in China. It currently has negative earnings. The Company’s technology, the Gridsum Big Data Platform performs multi-dimensional correlation analysis and analyzes real-time events.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>